CLINICAL CASE OF RESUMPTION OF ANTICOAGULANT THERAPY AFTER IMPLANTATION OF THE AMPLATZER CARDIAC PLUG LEFT ATRIAL APPENDAGE OCCLUDER
R. V. Guchaev,
D. V. Pevzner,
E. V. Merkulov,
M. I. Makeev,
N. S. Zhukova,
R. M. Shakhnovich,
T. Yu. Vedenikin,
N. V. Shestakova
Affiliations
R. V. Guchaev
Federal state budget organization «National medical research center of cardiology» of the Ministry of healthcare City Clinical Hospital named after V. V. Veresaev of the City of Moscow
D. V. Pevzner
Federal state budget organization «National medical research center of cardiology» of the Ministry of healthcare
E. V. Merkulov
Federal state budget organization «National medical research center of cardiology» of the Ministry of healthcare
M. I. Makeev
Federal state budget organization «National medical research center of cardiology» of the Ministry of healthcare
N. S. Zhukova
Federal state budget organization «National medical research center of cardiology» of the Ministry of healthcare
R. M. Shakhnovich
Federal state budget organization «National medical research center of cardiology» of the Ministry of healthcare
T. Yu. Vedenikin
City Clinical Hospital named after V. V. Veresaev of the City of Moscow
N. V. Shestakova
Federal State Budgetary Educational Institution of Additional Professional Education «Russian Medical Academy of Continuing Professional Education» of the Ministry of Health
The article demonstrates a clinical case of forced renewal of anticoagulant therapy after the endovascular closure of the left atrial appendage. Patient with atrial fibrillation and high risk of thromboembolic complications and bleeding on the background of warfarin administration and inappropriate INR values had an acute hemorrhagic cerebral blood flow disorder developed. Endovascular closure of the left atrial appendage was performed. However, the thrombosis of the area of the delivery system fastening revealed after 12 months was an indication for the resumption of anticoagulant therapy.The article presents modern data on the use of occluders for closing the left atrial appendage, the frequency of complications and antiplatelet therapy schemes depending on the presence of thrombosis risk factors and bleeding.
